InsiderTrades

Form 4 for HIG Hartford (The)

Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001225208-25-005273 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-05-19 2025-05-15 HIG TOOKER ADIN M Pres S - Sale+OE $128.61 -21.9K 47.2K -32% -$2.82M
DM 2025-05-19 2025-05-15 HIG TOOKER ADIN M Pres M - OptEx $49.10 +21.9K 40.0K +121% +$1.08M
DM 2025-05-19 2025-05-15 HIG TOOKER ADIN M Pres M - OptEx $0.00 -21.9K 6,731 -76% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-15 S D 4,005 $129.26 36,024.07 D — — (F6) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.68 - $129.64 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2025-05-15 S D 3,583 $128.00 40,029.07 D — — (F5) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.52 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2025-05-15 S D 3,563 $128.02 43,612.07 D — — (F4) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.64 - $128.61 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2025-05-15 S D 3,168 $129.28 50,456.07 D — — (F2) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.69 - $129.63 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2025-05-15 M A 6,731 $48.89 53,624.07 D — —
6 Common Common Stock 2025-05-15 M A 6,864 $43.59 46,893.07 D — —
7 Common Common Stock 2025-05-15 M A 8,308 $53.81 40,029.07 D — —
8 Common Common Stock 2025-05-15 S D 4,303 $128.01 31,721.07 D — — (F7) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $127.67 - $128.65 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
9 Common Common Stock 2025-05-15 S D 3,281 $129.28 47,175.07 D — — (F3) Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $128.65 - $129.60 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
10 Derivative Stock Option 2025-05-15 M D 6,864 $0.00 0 D $43.59 · — to 2026-03-01 6,864 Common Stock (F10) The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
11 Derivative Stock Option 2025-05-15 M D 8,308 $0.00 16,614 D $53.81 · — to 2028-02-27 8,308 Common Stock (F8) The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
12 Derivative Stock Option 2025-05-15 M D 6,731 $0.00 6,731 D $48.89 · — to 2027-02-28 6,731 Common Stock (F9) The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.